Taken together, the data demonstrated that MortaparibPlus possesses the ability to inactivate the DNA-damage-repair signalling and causes growth arrest/apoptosis of cancer cells by multiple p53-dependent and -independent modalities. This evidence concerns the gene TP53 and cancer.